<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-06-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>2060-AS38</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>201410</PUBLICATION_ID>
            <PUBLICATION_TITLE>The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>2060</CODE>
            <NAME>Air and Radiation</NAME>
            <ACRONYM>AR</ACRONYM>
        </AGENCY>
        <PARENT_AGENCY>
            <CODE>2000</CODE>
            <NAME>Environmental Protection Agency</NAME>
            <ACRONYM>EPA</ACRONYM>
        </PARENT_AGENCY>
        <RULE_TITLE>Protection of Stratospheric Ozone: Extension of the Laboratory and Analytical Use Exemption for Essential Class I Ozone-Depleting Substances</RULE_TITLE>
        <ABSTRACT><![CDATA[<!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>The Laboratory and Analytical Use Exemption allows for the limited production and import of small quantities of ozone-depleting substances for use in laboratories. Laboratory uses include equipment calibration; use as extraction solvents, diluents or carriers for chemical analysis; and biochemical research. This exemption is permitted under the Montreal Protocol on Substances that Deplete the Ozone Layer but is currently set to expire on December 31, 2014. The Parties to the Montreal Protocol are expected to take action to renew this exemption in November 2014. The lab use exemption in EPA's regulations is currently in effect only through December 31, 2014, consistent with the date under the Montreal Protocol. This rule would extend its effectiveness.</p>
</body>
</html>]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>First Time Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Proposed Rule Stage</RULE_STAGE>
        <MAJOR>No</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>40 CFR 82</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>42 USC 7414</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 7601</LEGAL_AUTHORITY>
            <LEGAL_AUTHORITY>42 USC 7671 to 7671q</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST/>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>NPRM</TTBL_ACTION>
                <TTBL_DATE>11/10/2014</TTBL_DATE>
                <FR_CITATION>79 FR 66679</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Comment Period End</TTBL_ACTION>
                <TTBL_DATE>12/10/2014</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Final Rule</TTBL_ACTION>
                <TTBL_DATE>02/00/2015</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <ADDITIONAL_INFO>Docket #:EPA-HQ-OAR-2014-0621</ADDITIONAL_INFO>
        <RFA_REQUIRED>No</RFA_REQUIRED>
        <SMALL_ENTITY_LIST>
            <SMALL_ENTITY>No</SMALL_ENTITY>
        </SMALL_ENTITY_LIST>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>Federal</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <FURTHER_INFO_URL>http://www.epa.gov/ozone/title6/exemptions/laboratory.html</FURTHER_INFO_URL>
        <NAICS_LIST>
            <NAICS>
                <NAICS_CD>325412</NAICS_CD>
                <NAICS_DESC>Pharmaceutical Preparation Manufacturing</NAICS_DESC>
            </NAICS>
        </NAICS_LIST>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>No</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Jeremy</FIRST_NAME>
                <LAST_NAME>Arling</LAST_NAME>
                <AGENCY>
                    <CODE>2060</CODE>
                    <NAME>Office of Air and Radiation</NAME>
                    <ACRONYM>OAR</ACRONYM>
                </AGENCY>
                <PHONE>202 343-9055</PHONE>
                <FAX>202 343-2338</FAX>
                <EMAIL>arling.jeremy@epa.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>1200 Pennsylvania Avenue NW, Mail Code 6205T,</STREET_ADDRESS>
                    <CITY>Washington</CITY>
                    <STATE>DC</STATE>
                    <ZIP>20460</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
            <CONTACT>
                <FIRST_NAME>David</FIRST_NAME>
                <LAST_NAME>Donaldson</LAST_NAME>
                <AGENCY>
                    <CODE>2060</CODE>
                    <NAME>Office of Air and Radiation</NAME>
                    <ACRONYM>OAR</ACRONYM>
                </AGENCY>
                <PHONE>202 343-9086</PHONE>
                <EMAIL>donaldson.david@epa.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>6205T,</STREET_ADDRESS>
                    <CITY>Washington</CITY>
                    <STATE>DC</STATE>
                    <ZIP>20460</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
